Table 2. Evaluations of statistical significance and power (1-β) values in comparison of age groups. Red bolds indicate P < 0.05 (statistical significance) and power values over 0.8.
Comparison | Anti-HERVK-env su IgM | Anti-HERVK-env peptide 92-93 IgM | Anti-HERVK-env su IgG | |||
---|---|---|---|---|---|---|
P value | Power (1-β error) | P value | Power (1-β error) | P value | Power (1-β error) | |
20s vs 30s | 0.18 | 0.75 | 0.80 | 0.55 | 0.38 | 0.68 |
20s vs 40s | < 0.0001 | 0.98 | 0.53 | 0.63 | 0.005 | 0.92 |
20s vs 50s | < 0.0001 | 0.99 | 0.0003 | 0.96 | 0.002 | 0.94 |
20s vs 60s and over | < 0.0001 | 0.99 | < 0.0001 | 0.98 | 0.003a | 0.94a |
30s vs 40s | 0.002 | 0.94 | 0.34 | 0.68 | 0.04 | 0.83 |
30s vs 50s | 0.0003 | 0.97 | 0.002 | 0.95 | 0.02 | 0.88 |
30s vs 60s and over | < 0.0001 | 0.99 | 0.0007 | 0.97 | 0.03a | 0.88a |
40s vs 50s | 0.19 | 0.73 | 0.03 | 0.89 | 0.45 | 0.68 |
40s vs 60s | 0.0003 | 0.97 | 0.01 | 0.93 | 0.27 | 0.73 |
50s vs 60s and over | 0.03 | 0.86 | 0.06 | 0.83 | 0.57 | 0.62a |
Breast cancer group was excepted from 60s and over group.